





IMPORTANT!
THE SERVICE REQUIRES THE AVAILABILITY OF YOUR GENETIC FILE.
If you do not have your genetic file, start with the Prisma test: it contains everything you need to collect a DNA sample.
Genetic analysis of 20 indicators related to brain function and mental health. Assessment of genetic features of brain function: memory, concentration, susceptibility to neurodegenerative changes and individual profile of mood and emotional regulation.
Take the test once — results can be updated according to changes in the scientific basis.
20 indicators in 4 categories: cognitive function, neurodegenerative risks, mental health, mood and character
Saliva collection for DNA sample at home - no blood, no clinic, no prior preparation
Structured report in your personal account with a genetic profile for each indicator
Personalized recommendations for cognitive load, sleep, and nutritional support for the nervous system
One saliva sample for DNA is the basis for analysis of any other Apixmed Prism panels without repeated sampling
Data is protected in accordance with ISO 27001, GDPR and HIPAA standards
Report language: Ukrainian

The brain's functioning is determined not only by lifestyle and environment. The synthesis of neurotransmitters, the speed of cognitive recovery, and the sensitivity to stress signals — a DNA neurotransmitter test evaluates the genetic basis of each of these processes. For example, dopamine and serotonin genetics: variants in genes associated with serotonin transport and dopamine metabolism affect an individual's response to stress and motivation, regardless of external circumstances. The tendency to decline in cognitive functions with age is partly due to genetic factors that can be assessed long before the first signs appear.
This genetic mental health test assesses characteristics across 20 indicators, from cognitive function and neurodegenerative risks to mental health predispositions and mood characteristics. These psychogenetics data are stable throughout life and complement a specialist's clinical assessment.
Four indicators that capture the genetic characteristics of intellectual productivity and the preservation of cognitive resources.
Intelligence and cognitive function — genetic factors related to neuroplasticity, information processing, speed of thinking, and learning ability are analyzed.
Memory — genetic characteristics that affect the efficiency of memory formation and reproduction are determined.
Cognitive decline — genetic factors predisposing to age-related cognitive decline are assessed.
Four indicators associated with genetic predisposition to neurodegenerative conditions.
Brain aging — genetic factors that influence the rate of age-related changes in the nervous system are analyzed.
Dementia and Alzheimer's disease — this genetic Alzheimer's test identifies features associated with a predisposition to neurodegenerative processes. Genetic predisposition is not a diagnosis, but can be the basis for a preventive approach together with a doctor.
Parkinson's disease — genetic risk factors associated with degeneration of dopaminergic neurons are being evaluated.
Six indicators that capture genetic features in the context of psychiatric conditions. Genetic data in this category is not a diagnostic tool—it describes predispositions, not determines the development of a condition.
Schizophrenia and bipolar disorder — genetic factors associated with the neurobiological features of these conditions are analyzed.
OCD and panic attacks — as part of a genetic anxiety test, features of the regulation of the anxiety response are determined.
PTSD — genetic factors that influence an individual's response to traumatic experiences are being assessed.
ADHD - genetic features associated with the regulation of attention and impulsivity are analyzed.
Six indicators covering genetic features of emotional regulation and personality characteristics.
Depression and anxiety — genetic factors associated with the exchange of neurotransmitters and susceptibility to the corresponding conditions are being identified.
Mood instability — genetic features of emotional regulation affecting emotional stability are analyzed.
Optimism and conscientiousness — genetic factors associated with stable personality characteristics are assessed.
Loneliness — genetic features of the subjective perception of social isolation are determined.
For people who want to better understand the individual characteristics of their cognitive performance - memory, concentration, and resistance to stress.
For those with a family history of neurodegenerative diseases — to assess genetic factors and develop a preventive approach together with a doctor.
For people working with a psychologist or psychiatrist: a genetic mental health test complements the clinical picture and helps in choosing support approaches.
For those who notice mood instability, increased anxiety, or decreased cognitive resource: a genetic depression and anxiety test helps understand the genetic component of these characteristics.
The results of the Mental Health and Brain genetic test are not a diagnosis and are not a substitute for consultation with a doctor or psychiatrist. The Apixmed Prism report provides genetic context - data that can complement clinical assessment and help make prevention and lifestyle decisions together with a specialist.